R&D News | pharmaphorum

News

Closeup of X-ray photography of human brain

Merck swings back into Alzheimer's with $1.1bn Cerevance all...

Merck & Co's earlier efforts to find new therapies for Alzheimer's disease resulted in failure, but the company is returning to the field via an R&D alliance with UK biotech Cerevan

News

Verona cues up filings for COPD drug after it aces phase 3 t...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next

News

Tagrisso paired with Hutchmed drug clears lung cancer test

EGFR inhibitors like AstraZeneca's Tagrisso have been hugely successful in treating EGFR-positive lung cancer, but the durability of treatment is often reduced by resistance mutations.

News

x-ray image of human head with brain and electric pulses

Sanofi pauses enrolment in ex-US tolebrutinib trials

Sanofi has paused recruitment in its international phase 3 trials of BTK inhibitor tolebrutinib for multiple sclerosis, although it says studies aimed at getting US approval are on track to

News

Fake Dictionary, Dictionary definition of the word Schizophrenia.

Sosei Heptares banks $30m milestone in Neurocrine Bio allian...

Sosei Heptares has taken another of its partnered G protein-coupled receptor (GPCR) programmes into mid-stage clinical trials, earning a $30 million milestone payment from Neurocrine Biosci

News

Gilead snaps up MiroBio and its checkpoint agonists for $405...

Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is heading for a takeover by Gilead Sciences in a $405 million deal.

Merck swings back into Alzheimer's with $1.1bn Cerevance all...

Verona cues up filings for COPD drug after it aces phase 3 t...

Tagrisso paired with Hutchmed drug clears lung cancer test

Sanofi pauses enrolment in ex-US tolebrutinib trials

Sosei Heptares banks $30m milestone in Neurocrine Bio allian...

Gilead snaps up MiroBio and its checkpoint agonists for $405...

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks